跳至主要内容
临床试验/NCT02982135
NCT02982135Unknown不适用

Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease:a Prospective Multi-center Cohort Study

liuxingju1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1
主要终点
rebleeding events

研究概览

简要总结

The investigators conducted a prospective multi-center study assessing the effect of direct bypass and indrect bypass in treatment of hemorrhagic moyamoya disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • cerebral digital subtraction contrast angiography (DSA) revealed severe stenosis or occlusion of the distal internal carotid or proximal middle and anterior cerebral arteries with prominent lenticulostriate "moyamoya collaterals"
  • patients had experienced at least one intracranial hemorrhage which was verified by computed tomography (CT) scanning, magnetic resonance imaging MRI), or lumbar puncture.
  • Patients requiring surgery

排除标准

  • Patient whose initial onset was marked by ischemia but subsequently suffered from intracranial hemorrhage
  • patients refused to participate in the study

结局指标

主要结局

rebleeding events

时间窗: 5-10 years

次要结局

  • postoperative compilications(30 days)
  • ischemic events(5-10 years)

研究者

发起方
liuxingju
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

liuxingju

Principal investigator

Ministry of Science and Technology of the People´s Republic of China

研究点 (1)

Loading locations...

相似试验